Dustin A. Heldman
Dustin A. Heldman publishes mostly in Neurology, Cognitive Neuroscience and Cellular and Molecular Neuroscience, on topics such as Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments and Botulinum Toxin and Related Neurological Disorders.
- World rank
- #733,470 of 7,710,434 ranked researchers
- Rank in United States
- #246,923 of 1,627,098
- Works
- 46
- Citations
- 2.1k
- Citations per work
- 45.9
What does Dustin A. Heldman research?
Dustin A. Heldman's work is mostly in Medicine (67%), Neuroscience (17%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3371.2%
- Medicine3167.2%
- Health Professions24.0%
- Life Sciences816.8%
- Neuroscience816.8%
- Everything else49.6%
- Physical Sciences12.4%
- Engineering12.4%
- 1Neurology62% of their works
- 2Cognitive Neuroscience11% of their works
- 3Cellular and Molecular Neuroscience6% of their works
- 4Psychiatry and Mental health5% of their works
- 5Physical Therapy, Sports Therapy and Rehabilitation4% of their works
- 6Biomedical Engineering2% of their works
Research topics
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders
- Parkinson's Disease and Spinal Disorders
- EEG and Brain-Computer Interfaces
- Balance, Gait, and Falls Prevention
- Cerebral Palsy and Movement Disorders
- Neuroscience and Neural Engineering
Which keywords describe Dustin A. Heldman's research?
The keywords of their largest research topics: Parkinson's Disease, Neurological Disorders, Deep Brain Stimulation, Basal Ganglia, Subthalamic Nucleus, a-Synuclein, Neurodegeneration and Botulinum Toxin.
- Electrode Arrays
- Gait Speed
- Cerebral Palsy
- Brain-Computer Interfaces
- Dropped Head Syndrome
- Botulinum Toxin
- Neurodegeneration
- Basal Ganglia
- Neurological Disorders
- Parkinson's Disease
- Deep Brain Stimulation
- Subthalamic Nucleus
- a-Synuclein
- Camptocormia
- Neurotoxins
- EEG Analysis
- Fall Risk
- ICF Model
- Neural Stimulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Parkinson's Disease754 topics
- Neurological Disorders503 topics
- Deep Brain Stimulation422 topics
- Basal Ganglia341 topic
- Subthalamic Nucleus341 topic
- Neurodegeneration281 topic
- a-Synuclein281 topic
- Botulinum Toxin81 topic
- Camptocormia81 topic
- Dropped Head Syndrome81 topic
- Neurotoxins81 topic
- Brain-Computer Interfaces61 topic
- EEG Analysis61 topic
- Cerebral Palsy51 topic
- Fall Risk51 topic
- Gait Speed51 topic
- ICF Model51 topic
- Electrode Arrays41 topic
- Neural Stimulation41 topic
Where does Dustin A. Heldman work?
Dustin A. Heldman's main affiliation in the publication record is Great Lakes NeuroTechnologies (United States), United States.
How many publications and citations does Dustin A. Heldman have?
OpenAlex counts 46 works and 2,111 citations for Dustin A. Heldman, an h-index of 22, ranking #733,470 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dustin A. Heldman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.